Qualitek Labs Ltd

Qualitek Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Qualitek Labs Ltd

₹ 260 -0.12%
21 Nov - close price
qualiteklab.com BSE - SME: 544091
About

Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.[1]

Key Points

Business Profile[1] Qualitek Labs Ltd. (QLL) provides testing, inspection, homologation, certification, and consultancy services to various industries viz automotive, defense, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.

Website BSE
  • Market Cap ₹ 192 Cr.
  • Current Price ₹ 260
  • High / Low ₹ 370 / 140
  • Stock P/E 47.8
  • Book Value ₹ 112
  • Dividend Yield 0.00 %
  • ROCE 17.3 %
  • ROE 20.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 30.1%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Part of BSE SME IPO

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Sep 2023 Mar 2024 Sep 2024
11.12 12.49 16.69 20.93
8.05 8.74 12.38 16.45
Operating Profit 3.07 3.75 4.31 4.48
OPM % 27.61% 30.02% 25.82% 21.40%
0.02 0.02 0.06 0.01
Interest 0.37 0.48 0.43 0.69
Depreciation 0.45 0.59 0.81 1.46
Profit before tax 2.27 2.70 3.13 2.34
Tax % 28.19% 25.56% 26.52% 26.92%
1.63 2.01 2.30 1.71
EPS in Rs 3.01 3.72 3.12 2.32
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
6.35 11.96 19.14 29.18 37.62
5.32 9.65 13.84 21.11 28.83
Operating Profit 1.03 2.31 5.30 8.07 8.79
OPM % 16.22% 19.31% 27.69% 27.66% 23.37%
0.02 0.05 0.18 0.08 0.07
Interest 0.01 0.32 0.70 0.93 1.12
Depreciation 0.35 0.50 0.84 1.40 2.27
Profit before tax 0.69 1.54 3.94 5.82 5.47
Tax % 33.33% 26.62% 25.13% 26.12%
0.46 1.14 2.94 4.31 4.01
EPS in Rs 460.00 24.78 5.44 5.85 5.44
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 66%
TTM: 59%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 111%
TTM: 10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 30%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.01 0.46 5.41 7.37 9.98
Reserves -0.24 1.44 4.49 25.08 72.26
11.22 17.29 23.45 12.25 14.85
3.61 3.01 6.24 5.89 11.80
Total Liabilities 14.60 22.20 39.59 50.59 108.89
6.33 7.57 13.67 29.51 42.64
CWIP 4.47 4.47 14.85 7.61 0.30
Investments 0.01 0.01 0.00 0.00 37.99
3.79 10.15 11.07 13.47 27.96
Total Assets 14.60 22.20 39.59 50.59 108.89

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024
1.35 -5.12 7.22 5.16
-6.07 -1.73 -17.41 -11.27
4.82 6.74 10.51 6.17
Net Cash Flow 0.10 -0.11 0.33 0.06

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 68.98 66.84 111.18 98.19
Inventory Days
Days Payable
Cash Conversion Cycle 68.98 66.84 111.18 98.19
Working Capital Days -52.88 122.07 50.73 64.29
ROCE % 12.33% 17.78% 17.30%

Shareholding Pattern

Numbers in percentages

3 Recently
Mar 2024Sep 2024
73.35% 73.35%
0.00% 0.02%
26.65% 26.62%
No. of Shareholders 646632

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.